Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Apr 2021 for LogicBio Therapeutics, Inc., €14k.
Filing timeline
BuySaleKyle Chiang
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Kyle Chiang: trading record in brief
All filings by Kyle Chiang on record concern LogicBio Therapeutics, Inc. Over a trading history stretching from 15 April 2021 to 16 April 2021, the count stands at 2 filings.
No open-market purchase appears, only 1 sale worth €14k. Other entries cover 1 option exercise.
The record was last updated on 19 April 2021 with an open-market sale (€14k) in LogicBio Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kyle Chiang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,977 shares@ US$5.73100.0% of flowCommon StockSEC:0001209191-21-027460:1
9,360 sharesCommon StockSEC:0001209191-21-027460:0
2 of 2 declarations
